Provider QP95-21 Update for New to Market Medical Drugs: triamcinolone acetonide injectable suspension (Xipere) and vutrisiran Read More
Provider QP97-21 MHCP Pharmacy Benefit Exclusion for Asparlas™, Khapzory™, Nulojix®, Oncaspar® and Susvimo™ Read More
